roche aur eli lilly alzaimar ki bemari ke liye khoon ka test tayyar karne ke liye afwaj mein shaamil ho rahay hain aur Amrici regulatory manzoori haasil karne ke maqsad ke sath senkron raza karon par mushtamil do sala clinical trial shuru karne ka mansoobah bana rahay hain .
budh ke roz aik bayan mein is koshish ki naqaab kushai ki gayi, lali ke sath sath eisai ( 4523. t ) aur biogen ( biib. o ) adwiyaat farokht karne ki tayari kar rahay hain jis ka maqsad dimagh ko lotney wali bemari ki paish qadmi ko kam karna hai, lekin un ka istemaal aaj ke mamool ke muqablay mein bemari ke ibtidayi marahil mein tashkhees ki zaroorat hai .
روشے holding ae jee aglay 18 se 24 mahino ke douran ڈیمنشیا ki ibtidayi alamaat ke sath kayi so raza karon ko bharti kere ga jis ke trial data mumkina tor par 2025 mein Amrici regulatory faylng ke liye tayyar hon ge, روشے dayignostk mein پرسنلائزڈ health care سلوشنز ke rehnuma bros jardn ne writers ko bataya .
you s food and drug administration ( f d ae ) ne روشے se kaha hai ke woh primaray care sahuliyaat ya family doctoron mein mareezon ki aik qabil zikar tadaad ko bharti kere, jis ne is muqadmay ko” aik bohat bara iqdaam” bana diya hai kyunkay ڈیمنشیا ke liye ibtidayi madad haasil karne walon mein alzaimar ki sharah bohat ziyada hai. abhi tak ghair yakeeni .
” hum tasleem karte hain ke yeh woh cheez hai jisay kisi aik idaray ke paas khud hal karne ka behtareen mauqa nahi hai, is liye hum ne lali ke sath shiraakat daari ki,” jardn ne kaha .
eisai ( 4523. t ) aur biogen’ s ( biib. o ) dawa leqembi ne January mein aik taiz nazarsani ke amal ke tehat fda ki manzoori haasil ki, jisay therapy ki taraqqi mein aik ahem paish Raft ke tor par dekha jata hai .
” hum na qabil yaqeen had tak pur josh hain ke jald hi ilaaj ke aapshnz honay walay hain. .. . yaqeenan is ka testing ki maang par khasa assar parre ga,” urdan ne kaha .
adwiyaat aur tshkhisi bananay wali company roche ki janib se alzaimar ki apni jadeed tareen dawa tayyar karne ki koshishen guzashta saal nakaam ho gayeen, lekin test cuts aur manshiat ki tehqeeq par is ka kaam jari raha .
khoon ke test se zahreeley protein beta امیلائیڈ ke nishanaat ka pata chalta hai, jo alzaimar ke mareezon ke dimagh mein bantaa hai. leqembi manshiat ko dimagh se amyloid ko hataane ke liye dekhaya gaya hai aur lilly ki dawai umeed waar bhi isi usool par mabni hai .
roche ka test, jisay elecsys amyloid plasma panel ke naam se jana jata hai, mareez ke alzaimar ki haalat par qatee jawab faraham karne ke liye nahi banaya gaya hai balkay un logon ki shanakht ke liye banaya gaya hai jinhein ziyada mehangay aur boujhal tasdeeqi test jaisay pet scan ya reerh ki haddi ke seyal ke tajzia mein agay barhna chahiye .
roche khoon ke test ko farokht karne ki umeed karta hai, jis ka tajzia roche machinon ka istemaal karte hue mayaari لیبز mein kya jaye ga, is waday par ke is se sehat ki dekh bhaal ke nizaam ko pet scan ya reerh ki haddi ke seyal test ki zaroorat ko kam karne mein madad miley gi .
lali ne pehlay hi aik khoon ka test tayyar kya hai jo p-tau217 ko nishana banata hai, aik aur protein jo alzaimar ka ishara hai aur quanterix ke sath kaam kar raha hai .
quest diagnostics aur c2n diagnostics ne mukhtalif tareeqon ka istemaal karte hue alzaimar ke khoon ke test bhi shuru kiye hain .